{
    "nctId": "NCT05941598",
    "briefTitle": "Electroacupuncture for Chemotherapy-Related Cognitive Impairment",
    "officialTitle": "Electroacupuncture to Prevent Chemotherapy-Related Cognitive Impairment in Patients With Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Chemotherapy-Related Cognitive Impairment",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "The incidence of chemotherapy-related cognitive impairment (CRCI) at the end of chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Newly diagnosed with stage I-III breast cancer\n2. Scheduled to undergo chemotherapy\n3. Aged between 18 and 75 years\n4. MoCA score \u2265 26\n5. Voluntary agreement to participate in the study and sign an informed consent\n\nExclusion Criteria:\n\n1. Demonstrated tumor metastasis or recurrence\n2. Had a prior history of chemotherapy\n3. Reported a history of brain tumors, head trauma or stroke\n4. Were diagnosed with cognitive function-impaired disorders, such as Alzheimer's disease\n5. Were unable to cooperate with testing for any reasons\n6. Had severe hepatic or renal insufficiency\n7. Had hemorrhagic disorders, including von Willebrand disease, or were taking anticoagulant or antiplatelet medication\n8. Had an implanted cardiac pacemaker\n9. Had a history of alcohol abuse or drug addiction\n10. Were participating in another interventional trial",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}